Financhill
Back

Camurus AB 10K Form

Sell
23

CAMRF
Camurus AB

Last Price:
$55.00
Seasonality Move:
8.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CAMRF News And Ratings

See the #1 stock for the next 7 days that we like better than CAMRF

CAMRF Financial Statistics

Sales & Book Value

Annual Sales: $231M
Cash Flow: $22.9M
Price / Cash Flow: 42.55
Annual Sales: $7.67
Price / Book: 7.15

Profitability

EPS (TTM): 1.24430
Net Income (TTM): $74.8M
Gross Margin: $212.5M
Return on Equity: 19.19%
Return on Assets: 16.95%

Camurus AB Earnings Forecast

Key Camurus AB Financial Ratios

  • The Gross Profit Margin over the past 14 years for CAMRF is 92.00%.
  • The Selling, General & Administrative Expenses for CAMRF have been equal to 31.26% of Gross Profit Margin.
  • The Research & Development expenses have been 21.71% of Revenue.
  • The Interest Expense is 0.78% of Operating Income.
  • The Net Earning history of CAMRF is 32.47% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

Camurus AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CAMRF
Website: camurus.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 12.09
Quick Ratio: 11.32

Price-to-Earnings

Trailing P/E Ratio: 44
Forward P/E Ratio: 0

CAMRF Technical Analysis vs Fundamental Analysis

Sell
23
Camurus AB (CAMRF) is a Sell

Is Camurus AB a Buy or a Sell?

  • Camurus AB stock is rated a Sell
    The current Camurus AB [CAMRF] share price is $55.00. The Score for CAMRF is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.